Octagon Capital Advisors »

Cybin shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Cybin shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Cybin

Tip: Access up to 7 years of quarterly data

All positions including Cybin held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.4M 490k 8.89

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals (APLS)
Verona Pharma Sponsored Ads (VRNA)
Structure Therapeutics Sponsored Ads (GPCR)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Arrivent Biopharma (AVBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Nuvation Bio Com Cl A (NUVB)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Ocular Therapeutix (OCUL)
Miragen Therapeutics (VRDN)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Cogent Biosciences (COGT)
Bridgebio Pharma (BBIO)

View all positions for Octagon Capital Advisors

Top funds holding Cybin

Avidity Partners Management
Octagon Capital Advisors
Tang Capital Management
Ikarian Capital
PDS Planning
Alyeska Investment Group
Jane Street
Fore Capital
TD Waterhouse Canada
IAG Wealth Partners
Royal Bank of Canada
Bank of America Corporation
Crewe Advisors
Global Wealth Strategies & Associates
Advisor Group Holdings

View all funds holding Cybin